Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Недержание мочи у пациентов пожилого и старческого возраста

Литература

  1. Abrams P., Cardozo L., Fall M. et al. Standardisation Sub-Committee of the International Continence Society. The standardisation of terminology in lower urinary tract function: report from the standardization sub-committee of the International Continence Society. Urology. 2003 Jan; 61(1): 37-49.
  2. Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50(6):1306–14.
  3. Byles, J., et al. Living with urinary incontinence: a longitudinal study of older women. Age Ageing, 2009. 38: 333.
  4. Milsom I, Abrams P, Cardozo L, Roberts RG, Thuroff J, Wein AJ. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 2001; 87: 760-6.
  5. Клинические рекомендации Российского общества урологов под редакцией Аляева,– М -2017г..
  6. Steawart W.F., Van Rooyen J.B., Cundiff G.W. et al. Prevalence and burden of overactive bladder in the United States // World J Urol. 2003. № 20. С. 327–336.
  7. Omli R, Hunskaar S, Mykletun A, Romild U, Kuhry E. Urinary incontinence and risk of functional decline in older women: data from the Norwegian HUNT-study. BMC Geriatr. 2013; 13 (1):47.
  8. Holroyd-Leduc JM, Mehta KM, Covinsky KE. Urinary incontinence and its association with death, nursing home admission, and functional decline. J Am Geriatr Soc. 2004 May; 52(5):712-8.)
  9. Morrison A, Levy R. Fraction of nursing home admission attributable to urinary incontinence. Value Health 2006;9:272.
  10. Coyne KS, Wein A, Nicholson S. Economic burden of urgency urinary incontinence in the United States: a systematic review. J Manag Care Pharm 2014;20:130–40.
  11. Гериатрия: национальное руководство/ под редю О.Н. Ткачевой, Е.В. Фроловой, Н.Н. Яхно. – М: ГЭОТАР-Медиа, 2018. -608 с.
  12. Brown, J.S., et al. Measurement characteristics of a voiding diary for use by men and women with overactive bladder. Urology, 2003. 61: 802.
  13. Arinzon, Z., et al. Clinical presentation of urinary tract infection (UTI) differs with aging in women. Arch Gerontol Geriatr, 2012. 55: 145.
  14. Moore, E.E., et al. Urinary incontinence and urinary tract infection: temporal relationships in postmenopausal women. Obstet Gynecol, 2008. 111: 317.
  15. Gravas, S., et al., EAU Guidelines on the management of Non- Neurogenice Male LUTS, in EAU Guidelines. Edn. published at the 33rd EAU Annual Congress, Copenhagen, E.G. Office, Editor. 2018, EAU Guidelines Office Arnhem, The Netherlands.
  16. Ouslander, J.G., et al. Does eradicating bacteriuria affect the severity of chronic urinary incontinence in nursing home residents? Ann Intern Med, 1995. 122: 749.
  17. Buchsbaum, G.M., et al. Utility of urine reagent strip in screening women with incontinence for urinary tract infection. Int Urogynecol J Pelvic Floor Dysfunct, 2004. 15: 391.
  18. Brostrom, S., et al. Short-term reproducibility of cystometry and pressure-flow micturition studies in healthy women. Neurourol Urodyn, 2002. 21: 457.
  19. Broekhuis, S.R., et al. Reproducibility of same session repeated cystometry and pressure-flow studies in women with symptoms of urinary incontinence. Neurourol Urodyn, 2010. 29: 428.
  20. Bemelmans, B.L., et al. Evidence for early lower urinary tract dysfunction in clinically silent multiple sclerosis. J Urol, 1991. 145: 1219.
  21. Lewicky-Gaupp, C., et al. “The cough game”: are there characteristic urethrovesical movement patterns associated with stress incontinence? Int Urogynecol J Pelvic Floor Dysfunct, 2009. 20:
  22. Shek, K.L., et al. The effect of childbirth on urethral mobility: a prospective observational study. J Urol, 2010. 184: 629.
  23. Painter, V., et al. Does patient activity level affect 24-hr pad test results in stress-incontinent women? Neurourol Urodyn, 2012. 31: 143.
  24. Brukhard F.C.., et al. EAU guidelines on Urinary incontinence in adults European Association of Urology, 2017.
  25. Sarma, A.V., et al. Risk factors for urinary incontinence among women with type 1 diabetes: findings from the epidemiology of diabetes interventions and complications study. Urology, 2009. 73: 1203.
  26. Urinary incontinence in women: management 2013, National Institute for Health and Care Excellence.
  27. Brazzelli, M., et al. Absorbent products for containing urinary and/or fecal incontinence in adults. J Wound Ostomy Continence Nurs, 2002. 29: 45.
  28. Fader, M., et al. A multi-centre evaluation of absorbent products for men with light urinary incontinence. Neurourol Urodyn, 2006. 25: 689.
  29. Fader, M., et al. Absorbent products for urinary/faecal incontinence: a comparative evaluation of key product designs. Health Technol Assess, 2008.
  30. Moore, K.N., et al. Assessing comfort, safety, and patient satisfaction with three commonly used penile compression devices. Urology, 2004. 63: 150.
  31. Lipp, A., et al. Mechanical devices for urinary incontinence in women. Cochrane Database Syst Rev, 2014:
  32. Park, Y.I., et al. A method to minimize indwelling catheter calcification and bladder stones in individuals with spinal cord injury. J Spinal Cord Med, 2001. 24:
  33. Drake, M., et al., Conservative management in neuropathic urinary incontinence, in Incontinence, P. Abrams, L. Cardozo, S. Khoury & A. Wein, Editors. 2013, Health Publication: Plymouth:, 2013; pp. 827-1000
  34. Li, L., et al. Impact of hydrophilic catheters on urinary tract infections in people with spinal cord injury: systematic review and meta-analysis of randomized controlled trials. Arch Phys Med Rehabil, 2013. 94: 782.
  35. Jahn, P., et al. Types of indwelling urinary catheters for long-term bladder drainage in adults. Cochrane Database Syst Rev, 2012. 10:
  36. Hunter, K.F., et al. Long-term bladder drainage: Suprapubic catheter versus other methods: a scoping review. Neurourol Urodyn, 2013. 32: 944.
  37. Prieto, J., et al. Catheter designs, techniques and strategies for intermittent catheterisation: What is the evidence for preventing symptomatic UTI and other complications? A Cochrane systematic review. Eur Urol Suppl, 2014. 13: e762.
  38. Hakansson, M.A. Reuse versus single-use catheters for intermittent catheterization: what is safe and preferred? Review of current status. Spinal Cord, 2014. 52: 511.
  39. Arya, L.A., et al. Dietary caffeine intake and the risk for detrusor instability: a case-control study. Obstet Gynecol, 2000. 96: 85.
  40. Bryant, C.M., et al. Caffeine reduction education to improve urinary symptoms. Br J Nurs, 2002. 11: 560.
  41. Swithinbank, L., et al. The effect of fluid intake on urinary symptoms in women. J Urol, 2005. 174: 187.
  42. Tomlinson, B.U., et al. Dietary caffeine, fluid intake and urinary incontinence in older rural women. Int Urogynecol J Pelvic Floor Dysfunct, 1999.10: 22.
  43. Hunskaar, S. A systematic review of overweight and obesity as risk factors and targets for clinical intervention for urinary incontinence in women. Neurourol Urodyn, 2008. 27: 749.
  44. Subak, L.L., et al. Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med, 2009. 360: 481.
  45. Tomlinson, B.U., et al. Dietary caffeine, fluid intake and urinary incontinence in older rural women. Int Urogynecol J Pelvic Floor Dysfunct, 1999. 10: 22.
  46. Townsend, M.K., et al. Caffeine intake and risk of urinary incontinence progression among women. Obstet Gynecol, 2012. 119: 950.
  47. Dowd T.T. et al. Fluid intake and urinary incontinence in older community-dwelling women. О Community Health Nurs, 1996. 13:179 48.Hashim H. et al. How should patients with an overactive bladder manipulate their fluid intake? BJU Int, 2008. 102: 62.
  48. Bump, R.C., et al. Obesity and lower urinary tract function in women: effect of surgically induced weight loss. Am J Obstet Gynecol, 1992. 167: 392.
  49. Subak, L.L., et al. Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med, 2009. 360: 481.
  50. Eustice, S., et al. Prompted voiding for the management of urinary incontinence in adults. Cochrane Database Syst Rev, 2000:
  51. Flanagan, L., et al. Systematic review of care intervention studies for the management of incontinence and promotion of continence in older people in care homes with urinary incontinence as the primary focus (1966-2010). Geriatr Gerontol Int, 2012. 12: 600.
  52. Imamura, M., et al. Systematic review and economic modelling of the effectiveness and costeffectiveness of non-surgical treatments for women with stress urinary incontinence. Health Technol Assess, 2010. 14
  53. Shamliyan, T., et al., Nonsurgical Treatments for Urinary Incontinence in Adult Women: Diagnosis and Comparative Effectiveness. 2012, IUGA-ICS Conservative Management for Female Pelvic Floor Dysfunction: Rockville (MD).
  54. Glazener, C., et al. Urinary incontinence in men after formal one-to-one pelvic-floor muscle training following radical prostatectomy or transurethral resection of the prostate (MAPS): two parallel randomised controlled trials. Lancet, 2011. 378: 328.
  55. Berghmans, B., et al. Efficacy of physical therapeutic modalities in women with proven bladder overactivity. Eur Urol, 2002. 41: 581.
  56. Kim, H., et al. Effectiveness of multidimensional exercises for the treatment of stress urinary incontinence in elderly community-dwelling Japanese women: a randomized, controlled, crossover trial. J Am Geriatr Soc, 2007. 55: 1932.
  57. Sherburn, M., et al. Incontinence improves in older women after intensive pelvic floor muscle training: an assessor-blinded randomized controlled trial. Neurourol Urodyn, 2011. 30: 317.
  58. McFall, S.L., et al. Outcomes of a small group educational intervention for urinary incontinence: health-related quality of life. J Aging Health, 2000. 12: 301.
  59. Campbell, S.E., et al. Conservative management for postprostatectomy urinary incontinence. Cochrane Database Syst Rev, 2012. 1:
  60. Finazzi-Agro, E., et al. Percutaneous tibial nerve stimulation effects on detrusor overactivity incontinence are not due to a placebo effect: a randomized, double-blind, placebo controlled trial. J Urol, 2010. 184: 2001.
  61. Peters, K.M., et al. Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. J Urol, 2010. 183: 1438.
  62. American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults // Am. Geriatr. Soc. 2015. Vol. 63, N 11. P. 2227-2246.
  63. Hartmann, K.E., et al. Treatment of overactive bladder in women. Evid Rep Technol Assess (Full Rep), 2009: 1. https://www.ncbi.nlm.nih.gov/pubmed/19947666
  64. Chapple, C., et al. The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysis. Eur Urol, 2005. 48:
  65. McDonagh, M.S., et al., In: Drug Class Review: Agents for Overactive Bladder: Final Report Update 4. 2009: Portland (OR)]
  66. Reynolds, W.S., et al. Comparative Effectiveness of Anticholinergic Therapy for Overactive Bladder in Women: A Systematic Review and Meta- analysis. Obstet Gynecol, 2015. 125: 1423.
  67. Novara, G., et al. A systematic review and meta-analysis of randomized controlled trials with antimuscarinic drugs for overactive bladder. Eur Urol, 2008. 54: 740.
  68. Ancelin, M.L., et al. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ, 2006. 332: 455.
  69. Madhuvrata, P., et al. Which anticholinergic drug for overactive bladder symptoms in adults. Cochrane Database Syst Rev, 2012. 1: CD005429.
  70. DuBeau, C.E., et al. Incontinence in the frail elderly: report from the 4th International Consultation on Incontinence. Neurourol Urodyn, 2010. 29: 165.
  71. Fink, H.A., et al. Treatment interventions in nursing home residents with urinary incontinence: a systematic review of randomized trials. Mayo Clin Proc, 2008. 83: 1332.
  72. Minassian, V.A., et al. Randomized trial of oxybutynin extended versus immediate release for women aged 65 and older with overactive bladder: lessons learned from conducting a trial. J Obstet Gynaecol Can, 2007. 29: 726.
  73. Wagg, A., et al. Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis. Am J Geriatr Pharmacother, 2006. 4: 14
  74. Zinner, N., et al. Impact of solifenacin on quality of life, medical care use, work productivity, and health utility in the elderly: an exploratory subgroup analysis. Am J Geriatr Pharmacother, 2009. 7: 373.
  75. Michel, M.C., et al. Does gender or age affect the efficacy and safety of tolterodine? J Urol, 2002. 168: 1027.
  76. Dubeau, C.E., et al. Effect of fesoterodine in vulnerable elderly subjects with urgency incontinence: a double-blind, placebo controlled trial. J Urol, 2014. 191: 395.
  77. Pietzko, A., et al. Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers. Eur J Clin Pharmacol, 1994. 47: 337.
  78. Isik, A.T., et al. Trospium and cognition in patients with late onset Alzheimer disease. J Nutr Health Aging, 2009. 13: 672.
  79. Chapple, C.R., et al. Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability. Neurourol Urodyn, 2014. 33: 17.
  80. Wu, T., et al. The role of mirabegron in overactive bladder: a systematic review and meta-analysis. Urol Int, 2014. 93: 326.
  81. Li, J., et al. The role of duloxetine in stress urinary incontinence: a systematic review and metaanalysis. Int Urol Nephrol, 2013.
  82. Mariappan, P., et al. Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review. Eur Urol, 2007. 51: 67.
  83. Yumru, A.E., et al. The use of local 17beta-oestradiol treatment for improving vaginal symptoms associated with post-menopausal oestrogen deficiency. J Int Med Res, 2009. 37: 198.
  84. Cody, J.D., et al. Oestrogen therapy for urinary incontinence in post- menopausal women. Cochrane Database Syst Rev, 2012. 10. CD001405.
  85. Ford, A.A., et al. Mid-urethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev, 2015: CD006375.
  86. Brennand, E.A., et al. Five years after midurethral sling surgery for stress incontinence: obesity continues to have an impact on outcomes. Int Urogynecol J, 2017. 28: 621.
  87. Pushkar D, Kasyan G, Gvozdev M, Sosnowski R. Analysis of 1,000 cases of synthetic midurethral slings used for treatment of female urinary incontinence - a single-center experience. Cent European J Urol. 2011; 64(4):243-51.
  88. Franzen, K., et al. Surgery for urinary incontinence in women 65 years and older: a systematic review. Int Urogynecol J, 2015. 26: 1095.
  89. Serati, M., et al. Transobturator vaginal tape for the treatment of stress urinary incontinence in elderly women without concomitant pelvic organ prolapse: is it effective and safe? Eur J Obstet Gynecol Reprod Biol, 2013. 166: 107.
  90. Lapitan, M.C., et al. Open retropubic colposuspension for urinary incontinence in women. Cochrane Database Syst Rev, 2016. 2: CD002912
  91. Rehman, H., et al. Traditional suburethral sling operations for urinary incontinence in women. Cochrane Database Syst Rev, 2017. 7: CD001754.
  92. Campeau, L., et al. A multicenter, prospective, randomized clinical trial comparing tension-free vaginal tape surgery and no treatment for the management of stress urinary incontinence in elderly women. Neurourol Urodyn, 2007. 26: 990.
  93. Zhao, Y., et al., Bulking agents - An analysis of 500 cases and review of the literature. Clin Exp Obstet Gynecol, 2016. 43: 666.
  94. Hegde, A., et al. Three-dimensional endovaginal ultrasound examination following injection of Macroplastique for stress urinary incontinence: outcomes based on location and periurethral distribution of the bulking agent. Int Urogynecol J, 2013. 24: 1151.
  95. Imamoglu M. A. et al. The comparison of artificial urinary sphincter implantation and endourethral macroplastique injection for the treatment of postprostatectomy incontinence //European urology. – 2005. – Т. 47. – №. 2. – С. 209-213.
  96. Alan, C., et al. Efficacy of Duloxetine in the Early Management of Urinary Continence after Radical Prostatectomy. Curr Urol, 2015. 8: 43.
  97. Cornel, E.B., et al. Can advance transobturator sling suspension cure male urinary postoperative stress incontinence? J Urol, 2010. 183: 1459.
  98. Gill, B.C., et al. Patient perceived effectiveness of a new male sling as treatment for postprostatectomy incontinence. J Urol, 2010. 183: 247.
  99. Bauer, R.M., et al. Contemporary management of postprostatectomy incontinence. Eur Urol, 2011. 59: 985.
  100. Smith, P., et al. 1348 Hypercontinence and cuff erosion after artificial sphincter insertion: A comparisnon of cuff sizes and placement techniques. The Journal of Urology, 2011. 185: e538.
  101. Mehta, S., et al. Meta-analysis of botulinum toxin A detrusor injections in the treatment of neurogenic detrusor overactivity after spinal cord injury. Arch Phys Med Rehabil, 2013. 94: 1473.
  102. Mangera, A., et al. Contemporary management of lower urinary tract disease with botulinum toxin A: a systematic review of botox (onabotulinumtoxinA) and dysport (abobotulinumtoxinA). Eur Urol, 2011. 60: 784.
  103. Chapple, C., et al. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo- controlled trial. Eur Urol, 2013. 64: 249.
  104. Nitti, V.W., et al. Onabotulinumtoxin A for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial. J Urol, 2013. 189: 2186.
  105. Nitti, V.W., et al. Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study. J Urol, 2016. 196: 791.
  106. Weil, E.H., et al. Sacral root neuromodulation in the treatment of refractory urinary urge incontinence: a prospective randomized clinical trial. Eur Urol, 2000. 37: 161.
  107. Schmidt, R.A., et al. Sacral nerve stimulation for treatment of refractory urinary urge incontinence. Sacral Nerve Stimulation Study Group. J Urol, 1999. 162: 352.
  108. van Kerrebroeck, P.E., et al. Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol, 2007. 178: 2029.
  109. Kockelbergh, R.C., et al. Clam enterocystoplasty in general urological practice. Br J Urol, 1991. 68: 38.
  110. Cohen, A.J., et al. Comparative Outcomes and Perioperative Complications of Robotic Vs Open Cystoplasty and Complex Reconstructions. Urology, 2016. 97: 172.
  111. Greenwell, T.J., et al. Augmentation cystoplasty. BJU Int, 2001. 88: 511.
  112. Kockelbergh, R.C., et al. Clam enterocystoplasty in general urological practice. Br J Urol, 1991. 68: 38.
  113. Cochrane Database Syst Rev, 2012. 1: CD001843

Для продолжения работы требуется Регистрация
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Литература
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу

Оглавление

Данный блок поддерживает скрол*